FDA expands recall of Ambriola cheeses containing listeria, including New York

The recall includes grated Pecorino Romano cheese brands of Ambriola, Locatelli, Boar's Head, Sam's Club Member's Mark and ...
Fierce Pharma

FDA delays decision on Travere's Filspari in key kidney disease indication

Much is riding on Travere Therapeutics’ bid to gain an expansion for Filspari to treat focal segmental glomerulosclerosis ...
MedPage Today

Pazdur Tells of FDA Turmoil; Surgeon's Data Questioned; MAHA's Supplement Boom

Several of Khajuria's papers have received scrutiny on PubPeer for apparent plagiarism, text recycling, and statistical ...

FDA commissioner explains new food pyramid, encourages greater uptake of core childhood vaccines

Martin Makary, commissioner of the Food and Drug Administration, on the push against ultra processed foods and added sugar, ...

Supplement Recalled Over Potential ‘Life-Threatening’ Side Effects, FDA Reports

Modern Warrior Ready supplements were recalled by the FDA for undeclared ingredients that may cause life-threatening side ...

Fortress Biotech receives FDA approval for Zycubo to treat Menkes disease

Zycubo received breakthrough therapy, fast track, rare paediatric disease and orphan drug designations from the FDA.

iotaMotion Receives FDA Clearance for Expanded Pediatric Use of iotaSOFT® Robotic-Assisted Cochlear Implant Insertion System

Motion, Inc., creator of iotaSOFT®, the first and only FDA cleared robotic-assisted cochlear implant insertion system, today ...
MedPage Today on MSN

Rare Childhood Disorder Gets Its First FDA Drug Approval

The FDA approved copper histidinate (Zycubo) as the first treatment for Menkes disease in pediatric patients, the agency ...